D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 21,858 424 World Ranking 10356 National Ranking 372

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Pharmacology
  • Cancer

His scientific interests lie mostly in Pharmacology, Pharmacokinetics, Internal medicine, Adverse effect and Drug. His research in Pharmacology intersects with topics in Crossover study, Toxicity and Rifampicin. His Pharmacokinetics research incorporates themes from Hypericum, Warfarin and Dosing.

Andrew J. McLachlan usually deals with Internal medicine and limits it to topics linked to Anesthesia and Low back pain and Back pain. The study incorporates disciplines such as Physical therapy, Pharmacotherapy and Retrospective cohort study in addition to Adverse effect. He studied Confidence interval and Pediatrics that intersect with Polypharmacy.

His most cited work include:

  • Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. (580 citations)
  • Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. (580 citations)
  • Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. (323 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Pharmacokinetics, Pharmacology, Internal medicine, Pharmacy and Family medicine. His study looks at the relationship between Pharmacokinetics and fields such as Chromatography, as well as how they intersect with chemical problems. Adverse effect and Confidence interval are the primary areas of interest in his Internal medicine study.

Andrew J. McLachlan has included themes like Placebo and Intensive care medicine in his Adverse effect study. In Placebo, he works on issues like Clinical trial, which are connected to Physical therapy and Randomized controlled trial. In his research, Psychological intervention is intimately related to MEDLINE, which falls under the overarching field of Family medicine.

He most often published in these fields:

  • Pharmacokinetics (39.41%)
  • Pharmacology (39.03%)
  • Internal medicine (21.56%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (21.56%)
  • Pharmacy (16.54%)
  • MEDLINE (13.01%)

In recent papers he was focusing on the following fields of study:

Andrew J. McLachlan mostly deals with Internal medicine, Pharmacy, MEDLINE, Physical therapy and Health care. His Internal medicine study combines topics from a wide range of disciplines, such as Chronic pain and Oncology. His study in MEDLINE is interdisciplinary in nature, drawing from both Medical prescription, Pharmacotherapy and Dosing.

His research integrates issues of Acute low back pain, Low back pain, Quality of life, Intervention and Placebo in his study of Physical therapy. His work in Global health covers topics such as Mortality rate which are related to areas like Pharmacology. His study of Bioavailability is a part of Pharmacology.

Between 2017 and 2021, his most popular works were:

  • Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis (50 citations)
  • Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review. (44 citations)
  • Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines. (35 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Health care
  • Cancer

Pharmacy, Health care, Polypharmacy, Pharmacist and MEDLINE are his primary areas of study. Andrew J. McLachlan interconnects Psychiatry, Older population, Older people and Ambivalence in the investigation of issues within Polypharmacy. His MEDLINE research integrates issues from Deprescriptions, Gerontology, Openness to experience, Pharmacotherapy and Medical prescription.

His Medical prescription research is classified as research in Pharmacology. The Pharmacology study which covers CYP3A that intersects with Drug. His Intensive care medicine study also includes

  • Boswellia serrata extract and related Randomized controlled trial,
  • Treatment resistance, which have a strong connection to Pharmacokinetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Danijela Gnjidic;Sarah N. Hilmer;Sarah N. Hilmer;Fiona M. Blyth;Fiona M. Blyth;Vasi Naganathan;Vasi Naganathan.
Journal of Clinical Epidemiology (2012)

874 Citations

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.

Gustavo C. Machado;Chris G. Maher;Paulo H. Ferreira;Marina B. Pinheiro.
BMJ (2015)

511 Citations

Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.

Neal M. Davies;Andrew J. McLachlan;Ric O. Day;Kenneth M. Williams.
Clinical Pharmacokinectics (2000)

499 Citations

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

Nicole Lowres;Lis Neubeck;Glenn Salkeld;Ines Krass.
Thrombosis and Haemostasis (2014)

453 Citations

Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

Xuemin Jiang;Kenneth M. Williams;Winston S. Liauw;Alaina J. Ammit.
British Journal of Clinical Pharmacology (2004)

371 Citations

Medication withdrawal trials in people aged 65 years and older: a systematic review.

Shoba Iyer;Vasi Naganathan;Andrew J McLachlan;David G Le Couteur.
Drugs & Aging (2008)

325 Citations

Clinical pharmacology in the geriatric patient.

Sarah N. Hilmer;Andrew J. McLachlan;David G. Le Couteur.
Fundamental & Clinical Pharmacology (2007)

312 Citations

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

Alemayehu B Mekonnen;Andrew J McLachlan;Jo-anne E Brien.
BMJ Open (2016)

288 Citations

Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis.

Rafael Zambelli Pinto;Chris G. Maher;Manuela L. Ferreira;Mark Hancock.
Annals of Internal Medicine (2012)

286 Citations

Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial.

Christopher M Williams;Christopher M Williams;Christopher G Maher;Jane Latimer;Andrew J McLachlan.
The Lancet (2014)

282 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrew J. McLachlan

Sarah N. Hilmer

Sarah N. Hilmer

Royal North Shore Hospital

Publications: 171

Christopher G. Maher

Christopher G. Maher

University of Sydney

Publications: 103

David G. Le Couteur

David G. Le Couteur

University of Sydney

Publications: 70

Richard O. Day

Richard O. Day

University of New South Wales

Publications: 63

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 49

Michael S. Roberts

Michael S. Roberts

University of Queensland

Publications: 31

William W. Hope

William W. Hope

University of Liverpool

Publications: 31

Fiona M. Blyth

Fiona M. Blyth

University of Sydney

Publications: 29

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 29

Bart W. Koes

Bart W. Koes

Erasmus University Rotterdam

Publications: 27

Robert G. Cumming

Robert G. Cumming

University of Sydney

Publications: 26

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 26

Laxmaiah Manchikanti

Laxmaiah Manchikanti

University of Louisville

Publications: 24

Jeffrey Lipman

Jeffrey Lipman

Royal Brisbane and Women's Hospital

Publications: 24

Maurits W. van Tulder

Maurits W. van Tulder

Vrije Universiteit Amsterdam

Publications: 23

David J. Handelsman

David J. Handelsman

University of Sydney

Publications: 23

Trending Scientists

Frank Piessens

Frank Piessens

KU Leuven

José M. Merigó

José M. Merigó

University of Technology Sydney

George P. Huber

George P. Huber

The University of Texas at Austin

Dietrich Stoyan

Dietrich Stoyan

TU Bergakademie Freiberg

David J. Nesbitt

David J. Nesbitt

National Institute of Standards and Technology

Esmond E. Snell

Esmond E. Snell

University of California, Berkeley

Kazuhiro Sayama

Kazuhiro Sayama

National Institute of Advanced Industrial Science and Technology

Koji Suzuki

Koji Suzuki

Keio University

Douglas E. Brash

Douglas E. Brash

Yale University

Lígia Salgueiro

Lígia Salgueiro

University of Coimbra

Kevin D. Alloway

Kevin D. Alloway

Pennsylvania State University

John D. Altman

John D. Altman

Emory University

Jack T. Stapleton

Jack T. Stapleton

University of Iowa

Keijo Häkkinen

Keijo Häkkinen

University of Jyväskylä

Eddie C.M. Hui

Eddie C.M. Hui

Hong Kong Polytechnic University

Deborah C. Glik

Deborah C. Glik

University of California, Los Angeles

Something went wrong. Please try again later.